ChabiotechLtd Past Earnings Performance
Past criteria checks 0/6
ChabiotechLtd's earnings have been declining at an average annual rate of -58.2%, while the Healthcare industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 14% per year.
Key information
-58.2%
Earnings growth rate
-57.9%
EPS growth rate
Healthcare Industry Growth | 34.2% |
Revenue growth rate | 14.0% |
Return on equity | -0.8% |
Net Margin | -0.9% |
Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How ChabiotechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 953,951 | -8,431 | 234,340 | 14,614 |
30 Sep 23 | 942,431 | -31,870 | 236,336 | 14,455 |
30 Jun 23 | 921,073 | -39,266 | 228,951 | 13,999 |
31 Mar 23 | 892,981 | -37,037 | 221,264 | 14,586 |
31 Dec 22 | 844,583 | -47,543 | 214,937 | 14,359 |
30 Sep 22 | 808,777 | -4,922 | 197,996 | 13,787 |
30 Jun 22 | 779,374 | 602 | 182,069 | 13,369 |
31 Mar 22 | 747,666 | -21,366 | 183,234 | 12,791 |
31 Dec 21 | 727,476 | -13,968 | 173,414 | 13,050 |
30 Sep 21 | 704,072 | -26,755 | 167,570 | 13,401 |
30 Jun 21 | 694,812 | -31,561 | 171,881 | 13,895 |
31 Mar 21 | 677,277 | -16,194 | 162,588 | 13,453 |
31 Dec 20 | 664,717 | -18,658 | 161,030 | 13,457 |
30 Sep 20 | 655,853 | -7,667 | 152,994 | 11,890 |
30 Jun 20 | 590,893 | -8,520 | 150,872 | 12,206 |
31 Mar 20 | 565,529 | 49,125 | 146,292 | 12,234 |
31 Dec 19 | 534,612 | 46,375 | 144,877 | 11,328 |
30 Sep 19 | 500,910 | 46,386 | 148,328 | 10,419 |
30 Jun 19 | 515,232 | 51,595 | 142,656 | 8,408 |
31 Mar 19 | 502,201 | 19,231 | 141,164 | 7,464 |
31 Dec 18 | 488,600 | 24,698 | 128,341 | 6,771 |
30 Sep 18 | 502,360 | 1,516 | 123,733 | 6,202 |
30 Jun 18 | 467,869 | -12,462 | 118,957 | 7,391 |
31 Mar 18 | 435,256 | -37,872 | 107,689 | 8,690 |
31 Dec 17 | 417,460 | -45,585 | 112,514 | 9,462 |
30 Sep 17 | 402,155 | -20,436 | 105,054 | 15,492 |
30 Jun 17 | 416,750 | -9,272 | 103,467 | 13,124 |
31 Mar 17 | 434,669 | 1,024 | 99,217 | 10,609 |
31 Dec 16 | 449,261 | 11,448 | 98,697 | 8,876 |
30 Sep 16 | 428,117 | -6,336 | 143,894 | 3,503 |
30 Jun 16 | 423,770 | -8,274 | 126,777 | 3,446 |
31 Mar 16 | 410,812 | -10,394 | 111,844 | 3,448 |
31 Dec 15 | 393,782 | -14,956 | 95,604 | 3,373 |
30 Sep 15 | 424,074 | 1,805 | 32,316 | 2,298 |
30 Jun 15 | 386,370 | -562 | 29,124 | 2,085 |
31 Mar 15 | 361,625 | -2,257 | 33,988 | 1,746 |
31 Dec 14 | 345,345 | -4,721 | 35,417 | 1,569 |
30 Sep 14 | 298,626 | -12,157 | 42,711 | 1,203 |
30 Jun 14 | 323,263 | -5,312 | 48,846 | 1,126 |
31 Mar 14 | 370,749 | 4,712 | 50,281 | 958 |
31 Dec 13 | 386,835 | 11,308 | 53,852 | 1,018 |
30 Sep 13 | 429,783 | 27,802 | 53,384 | 1,177 |
30 Jun 13 | 489,822 | 35,947 | 56,604 | 1,327 |
Quality Earnings: A085660 is currently unprofitable.
Growing Profit Margin: A085660 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A085660 is unprofitable, and losses have increased over the past 5 years at a rate of 58.2% per year.
Accelerating Growth: Unable to compare A085660's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A085660 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4%).
Return on Equity
High ROE: A085660 has a negative Return on Equity (-0.85%), as it is currently unprofitable.